Over the last 7 days, the U.S. market has dropped 2.5%, though it has seen a significant rise of 23% over the past year, with earnings forecasted to grow annually by 17%. In light of these conditions, investors might find value in exploring stocks that offer affordability and growth potential, particularly those with strong financials. Although the term "penny stocks" may seem outdated, these smaller or newer companies continue to present intriguing opportunities for those seeking diversification beyond well-known names.

Here's a peek at a few of the choices from the screener.

Scienjoy Holding (SJ)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Scienjoy Holding Corporation operates mobile live streaming platforms in the People's Republic of China and has a market cap of $49.26 million.

Operations: The company's revenue primarily comes from its Internet Telephone segment, generating CN¥1.22 billion.

Market Cap: $49.26M

Scienjoy Holding Corporation, with a market cap of US$49.26 million, operates mobile live streaming platforms in China and has shown significant volatility in its share price recently. The company is debt-free, with short-term assets exceeding both short and long-term liabilities. Despite being unprofitable over the past five years with earnings declining significantly, recent results show a shift to profitability for Q1 2026 compared to the previous year. Trading at 74.7% below estimated fair value suggests potential undervaluation but comes with high risk due to past performance inconsistencies and high volatility relative to other US stocks.

TransAct Technologies (TACT)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: TransAct Technologies Incorporated designs, develops, and markets transaction-based and specialty printers and terminals both in the United States and internationally, with a market cap of $49.33 million.

Operations: The company generates revenue from its Software-Driven Technology and Printing Solutions segment, totaling $52.84 million.

Market Cap: $49.33M

TransAct Technologies, with a market cap of US$49.33 million, recently reported Q1 2026 sales of US$14.42 million and net income of US$0.766 million, indicating improved financial performance compared to the previous year. Despite being unprofitable overall, the company has a solid cash runway exceeding three years due to positive free cash flow growth and more cash than total debt. A recent OEM partnership with MedVantage highlights strategic expansion in healthcare and food service sectors, enhancing operational efficiency for clients. Upcoming leadership changes aim to strengthen its transition toward a recurring revenue model while maintaining stability through experienced management and board members.

eHealth (EHTH)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: eHealth, Inc. operates a health insurance marketplace offering consumer engagement, education, and enrollment solutions in the United States with a market cap of $54.91 million.

Operations: The company generates revenue primarily from its Medicare segment, which accounts for $508.82 million, and its Employer and Individual segment, contributing $20.09 million.

Market Cap: $54.91M

eHealth, Inc., with a market cap of US$54.91 million, remains unprofitable but has reduced losses over five years by 16.9% annually. Its revenue primarily stems from the Medicare segment, contributing significantly to its total revenue of US$508.82 million in this area alone. Despite high volatility and negative returns on equity, eHealth's short-term assets exceed liabilities by a large margin, indicating financial stability in the short term. Recent product expansion into Final Expense life insurance plans aligns with strategic growth efforts and addresses consumer needs for end-of-life expense coverage without requiring medical exams for eligibility.

Turning Ideas Into Actions

• Gain an insight into the universe of 335 US Penny Stocks by clicking here.
• Looking For Alternative Opportunities? We've found 10 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.